Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATP1A1 | P05023 | 3/20 | 1.00 |
| ▸ | ATP1B1 | P05026 | 3/20 | 1.00 |
| ▸ | ATP1A3 | P13637 | 3/20 | 1.00 |
| ▸ | ATP1B2 | P14415 | 3/20 | 1.00 |
| ▸ | ATP1A2 | P50993 | 3/20 | 1.00 |
| ▸ | ATP1B3 | P54709 | 3/20 | 1.00 |
| ▸ | FXYD2 | P54710 | 3/20 | 1.00 |
| ▸ | ATP1A4 | Q13733 | 3/20 | 1.00 |
| ▸ | ACE | P12821 | 2/20 | 1.00 |
| ▸ | MAOA | P21397 | 6/20 | 0.68 |
| ▸ | MGAM | O43451 | 6/20 | 0.65 |
| ▸ | GAA | P10253 | 5/20 | 0.65 |
| ▸ | SI | P14410 | 4/20 | 0.65 |
| ▸ | MGAM2 | Q2M2H8 | 4/20 | 0.65 |
| ▸ | CDK5 | Q00535 | 3/20 | 0.65 |
| ▸ | CDK5R1 | Q15078 | 3/20 | 0.65 |
| ▸ | CLK1 | P49759 | 1/20 | 0.65 |
| ▸ | CLK2 | P49760 | 1/20 | 0.65 |
| ▸ | CLK3 | P49761 | 1/20 | 0.65 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.65 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30436568 | 1.00 | ATP1A1 (1.00) | ATP1A1ATP1B1ATP1A3ATP1B2ATP1A2 | |
| SCHEMBL22137869 | 0.84 | ATP1A1 (0.72) | ATP1A1ATP1B1ATP1A3ATP1B2ATP1A2 | |
| SCHEMBL7230163 | 0.83 | ATP1A1 (0.70) | ATP1A1ATP1B1ATP1A3ATP1B2ATP1A2 | |
| SCHEMBL22325399 | 0.81 | MAOA (0.72) | ATP1A1ATP1B1ATP1A3ATP1B2ATP1A2 | |
| SCHEMBL31197649 | 0.81 | MAOA (0.72) | ATP1A1ATP1B1ATP1A3ATP1B2ATP1A2 | |
| SCHEMBL4743861 | 0.81 | MAOA (1.00) | ATP1A1ATP1B1ATP1A3ATP1B2ATP1A2 | |
| SCHEMBL29396825 | 0.81 | MAOA (1.00) | ATP1A1ATP1B1ATP1A3ATP1B2ATP1A2 | |
| SCHEMBL152329 | 0.81 | ACE (0.73) | ATP1A1ATP1B1ATP1A3ATP1B2ATP1A2 | |
| SCHEMBL149545 | 0.81 | MAOA (0.73) | ATP1A1ATP1B1ATP1A3ATP1B2ATP1A2 | |
| SCHEMBL11027790 | 0.80 | MAOA (0.70) | ATP1A1ATP1B1ATP1A3ATP1B2ATP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260007634-A1 | PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF ALLERGIC DISEASES | KINKI UNIVERSITY (JP) | 2026-01-08 | — | — | US | claimed |
| EP-4566599-A1 | PHARMACEUTICAL COMPOSITION FOR AMELIORATING ALLERGIC DISEASES | Kinki University (JP) | 2025-06-11 | — | — | EP | claimed |
| WO-2024029528-A1 | PHARMACEUTICAL COMPOSITION FOR AMELIORATING ALLERGIC DISEASES | 学校法人近畿大学 | 2024-02-08 | — | — | WO | claimed |
| WO-2020130102-A1 | COMPOSITION FOR IMPROVING AUTOIMMUNE DISEASE | 学校法人近畿大学 | 2020-06-25 | — | — | WO | claimed |
| US-20150272923-A1 | Na/K-ATPase Ligands, Ouabain Antagonists, Assays and Uses Thereof | THE UNIVERSITY OF TOLEDO (US) | 2015-10-01 | — | — | US | claimed |
| US-9062022-B2 | Polymer composition and dialysis membrane formed from the polymer composition | THE UNIVERSITY OF AKRON (US) | 2015-06-23 | — | — | US | claimed |
| US-20140031419-A1 | Na/K-ATPase Ligands, Ouabain Antagonists, Assays and Uses Thereof | THE UNIVERSITY OF TOLEDO (US) | 2014-01-30 | — | — | US | claimed |
| US-20110233138-A1 | POLYMER COMPOSITION AND DIALYSIS MEMBRANE FORMED FROM THE POLYMER COMPOSITION | THE UNIVERSITY OF AKRON | 2011-09-29 | — | — | US | claimed |
| US-20260007634-A1 | PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF ALLERGIC DISEASES | KINKI UNIVERSITY (JP) | 2026-01-08 | — | — | US | disclosed |
| US-20260007634-A1 | PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF ALLERGIC DISEASES | KINKI UNIVERSITY (JP) | 2026-01-08 | — | — | US | disclosed |
| EP-4566599-A1 | PHARMACEUTICAL COMPOSITION FOR AMELIORATING ALLERGIC DISEASES | Kinki University (JP) | 2025-06-11 | — | — | EP | disclosed |
| EP-4566599-A1 | PHARMACEUTICAL COMPOSITION FOR AMELIORATING ALLERGIC DISEASES | Kinki University (JP) | 2025-06-11 | — | — | EP | disclosed |
| US-20240389587-A1 | COMPOSITIONS AND METHODS FOR CONTROLLING PHYTOPATHOGENIC INFECTIONS | INSTITUT NATIONAL DE RECHERCHE POUR L'AGRICULTURE, L'ALIMENTATION ET L'ENVIRONNEMENT (INRAE) (FR) | 2024-11-28 | — | — | US | disclosed |
| JP-2024051068-A | Composition for improving autoimmune diseases | 学校法人近畿大学 | 2024-04-10 | — | — | JP | disclosed |
| US-20140031419-A1 | Na/K-ATPase Ligands, Ouabain Antagonists, Assays and Uses Thereof | THE UNIVERSITY OF TOLEDO (US) | 2014-01-30 | — | — | US | disclosed |
| US-20120302630-A1 | Na/K-ATPase Ligands, Ouabain Antagonists, Assays and Uses Thereof | CHINESE ACADEMY OF MEDICAL SCIENCES (CN) | 2012-11-29 | — | — | US | disclosed |
| US-20110233138-A1 | POLYMER COMPOSITION AND DIALYSIS MEMBRANE FORMED FROM THE POLYMER COMPOSITION | THE UNIVERSITY OF AKRON | 2011-09-29 | — | — | US | disclosed |
| US-20110233138-A1 | POLYMER COMPOSITION AND DIALYSIS MEMBRANE FORMED FROM THE POLYMER COMPOSITION | THE UNIVERSITY OF AKRON | 2011-09-29 | — | — | US | disclosed |
| US-20110233138-A1 | POLYMER COMPOSITION AND DIALYSIS MEMBRANE FORMED FROM THE POLYMER COMPOSITION | THE UNIVERSITY OF AKRON | 2011-09-29 | — | — | US | disclosed |
| US-20110186518-A1 | POLYMER COMPOSITION WITH PHYTOCHEMICAL AND DIALYSIS MEMBRANE FORMED FROM THE POLYMER COMPOSITION | THE UNIVERSITY OF AKRON (US) | 2011-08-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260007634-A1 | PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF ALLERGIC DISEASES | NFATC1, IL5, TRAF6 | ATP1A1 3205/4885ATP1B1 3652/4885ATP1A3 2034/4885 |
| US-20150272923-A1 | Na/K-ATPase Ligands, Ouabain Antagonists, Assays and Uses Thereof | ATP1A2, ATP1B1, ATP1A1 | ATP1A1 3/4885ATP1B1 2/4885ATP1A3 7/4885 |
| US-20110186518-A1 | POLYMER COMPOSITION WITH PHYTOCHEMICAL AND DIALYSIS MEMBRANE FORMED FROM THE POLYMER COMPOSITION | MATR3, ATP6V1B1, CD68 | ATP1A1 2821/4885ATP1B1 2883/4885ATP1A3 2761/4885 |
| US-20140031419-A1 | Na/K-ATPase Ligands, Ouabain Antagonists, Assays and Uses Thereof | ATP1A2, ATP1B1, ATP1A1 | ATP1A1 3/4885ATP1B1 2/4885ATP1A3 7/4885 |
| US-20120302630-A1 | Na/K-ATPase Ligands, Ouabain Antagonists, Assays and Uses Thereof | ATP1A2, ATP1A1, ATP1B1 | ATP1A1 2/4885ATP1B1 3/4885ATP1A3 5/4885 |
| US-20110233138-A1 | POLYMER COMPOSITION AND DIALYSIS MEMBRANE FORMED FROM THE POLYMER COMPOSITION | PROC, LNPK, F10 | ATP1A1 2528/4885ATP1B1 2752/4885ATP1A3 2950/4885 |
| US-20240389587-A1 | COMPOSITIONS AND METHODS FOR CONTROLLING PHYTOPATHOGENIC INFECTIONS | XBP1, ERN1, ERN2 | ATP1A1 3368/4885ATP1B1 3328/4885ATP1A3 3982/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.